TY  - JOUR 
AU  - St?pnicki, P.
AU  - Wronikowska-Denysiuk, O.
AU  - Zi?ba, A.
AU  - Targowska-Duda, K.M.
AU  - Bartyzel, A.
AU  - Wróbel, M.Z.
AU  - Wróbel, T.M.
AU  - Sza?aj, K.
AU  - Chodkowski, A.
AU  - Mirecka, K.
AU  - Budzy?ska, B.
AU  - Fornal, E.
AU  - Tur?o, J.
AU  - Castro Pérez, María de los Ángeles
AU  - Kaczor, A.A.
PY  - 2023
SN  - 1475-6374
UR  - http://hdl.handle.net/20.500.11940/21792
AB  - Schizophrenia is a chronic mental disorder that is not satisfactorily treated with available antipsychotics. The presented study focuses on the search for new antipsychotics by optimising the compound D2AAK3, a multi-target ligand of G-protein-coupled...
LA  - eng
KW  - Humans
KW  - Schizophrenia
KW  - Piperazine
KW  - Dopamine
KW  - Ligands
KW  - Indazoles
KW  - Serotonin
KW  - Receptors, Serotonin
KW  - Antipsychotic Agents
KW  - Receptor, Serotonin, 5-HT1A
TI  - Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation
DO  - 10.1080/14756366.2023.2209828
T2  - Journal of enzyme inhibition and medicinal chemistry
M2  - 2209828
KW  - IDIS
VL  - 38
ER  -